eMS News

At the Rocky Mountain MS Center, we believe general health and wellness are key components to living with multiple sclerosis. Maximizing lifelong brain health starts with overall wellness, and maintaining…

Last night, the FDA approved Ocrelizumab to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by…

Social Security has issued important new regulations which will go into effect for applications filed on or after March 27, 2017.  These regulations, in most cases, may make it harder…

The connection between multiple sclerosis and vitamin D levels is an area of study that has long been of interest to researchers and people who are living with MS. A…